Vishay Intertechnology
VSH
36.87
-0.97
-2.56%
Vishay Intertechnology
US · VSH
#1951 by market cap
Listed 1970
36.87
-0.97
-2.56%
Live - 5344 symbols - heartbeat 444s ago
· 2026-10-08 07:40
Pre-market
36.01
-2.33%
After-hours
36.90
+0.08%
Overnight
36.30
-1.55%
- Market cap
- 5.66B
- P/E (TTM)i
- 184.35
- P/Bi
- 1.94
- EPSi
- -0.07
- Div yieldi
- 1.08%
- 52W posi
- 44%
Reader sentiment
Are you bullish or bearish on VSH?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.98, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +4.48% YoY
Margins
- Gross margin
- 19.38%
- Operating margin
- 1.85%
- Net margin
- -0.29%
Key ratios & quality
- Enterprise valuei
- 6.12B
- Altman Z-Scorei
- 2.98
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.03B | 2.67B | 2.50B | 3.24B | 3.50B | 3.40B | 2.94B | 3.07B |
| Gross profit | 888.52M | 671.20M | 581.90M | 887.91M | 1.06B | 974.49M | 626.29M | 594.88M |
| Selling & admin expenses | 403.40M | 384.63M | 371.45M | 420.11M | 443.50M | 488.35M | 513.56M | 538.02M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 485.12M | 286.57M | 210.45M | 467.80M | 615.49M | 486.14M | 112.73M | 56.87M |
| Pretax profit | 416.78M | 226.30M | 158.33M | 434.61M | 593.51M | 467.40M | -2.39M | 25.51M |
| Tax | 70.24M | 61.51M | 34.55M | 135.67M | 163.02M | 141.89M | 27.37M | 34.49M |
| Net profit | 346.54M | 164.79M | 123.78M | 298.94M | 430.48M | 325.51M | -29.76M | -8.98M |
| Basic EPS | 2 | 1 | 1 | 2 | 3 | 2 | 0 | 0 |
| Diluted EPS | 2.24 | 1.13 | 0.85 | 2.05 | 2.98 | 2.31 | -0.23 | -0.07 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 715.24M | 762.25M | 790.64M | 800.92M | 839.24M | 888.58M |
| Gross profit | 135.55M | 148.68M | 153.86M | 156.79M | 176.61M | 207.38M |
| Selling & admin expenses | 134.74M | 126.57M | 134.71M | 142.00M | 154.49M | 153.86M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 815.00K | 22.12M | 19.15M | 14.79M | 22.12M | 53.53M |
| Pretax profit | -4.23M | 12.28M | 11.89M | 5.58M | 12.85M | 42.40M |
| Tax | -136.00K | 10.27M | 19.76M | 4.59M | 5.69M | 14.28M |
| Net profit | -4.09M | 2.00M | -7.88M | 986.00K | 7.16M | 28.12M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.03 | 0.01 | -0.06 | 0.01 | 0.05 | 0.19 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.78B | 1.70B | 1.70B | 2.01B | 2.12B | 2.30B | 1.92B | 1.89B |
| Cash & ST investments | 764.32M | 802.96M | 778.35M | 920.85M | 916.10M | 1.01B | 606.42M | 515.23M |
| Inventory | 479.66M | 431.68M | 448.25M | 536.50M | 618.88M | 647.52M | 689.38M | 759.20M |
| Total assets | 3.11B | 3.12B | 3.15B | 3.54B | 3.87B | 4.24B | 4.11B | 4.23B |
| Total current liabilities | 644.11M | 520.43M | 562.42M | 693.67M | 726.26M | 691.88M | 708.35M | 720.43M |
| Short-term debt | 18.00K | 20.22M | 22.07M | 23.39M | 25.32M | 26.49M | 25.90M | 26.55M |
| Long-term debt | 494.51M | 499.15M | 394.89M | 455.67M | 500.94M | 818.19M | 905.02M | 950.89M |
| Total liabilities | 1,719,512,000.00 | 1,632,912,000.00 | 1,575,288,000.00 | 1,796,537,000.00 | 1,815,503,000.00 | 2,039,117,000.00 | 2,081,734,000.00 | 2,145,887,000.00 |
| Total equity | 1.39B | 1.49B | 1.58B | 1.75B | 2.05B | 2.20B | 2.03B | 2.09B |
| Retained earnings | -61.26M | 72.18M | 138.99M | 401.69M | 773.23M | 1.04B | 955.50M | 892.23M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 1.98B | 1.91B | 1.89B | 1.89B | 1.88B | 2.72B |
| Cash & ST investments | 619.60M | 479.08M | 444.12M | 515.23M | 479.55M | 1.30B |
| Inventory | 712.44M | 754.87M | 759.92M | 759.20M | 790.78M | 807.11M |
| Total assets | 4.20B | 4.22B | 4.20B | 4.23B | 4.26B | 5.16B |
| Total current liabilities | 705.40M | 707.29M | 710.68M | 720.43M | 712.24M | 1.51B |
| Short-term debt | 26.18M | 26.99M | 26.32M | 26.55M | 26.17M | 765.99M |
| Long-term debt | 988.24M | 914.50M | 919.70M | 950.89M | 983.09M | 234.54M |
| Total liabilities | 2,168,110,000.00 | 2,126,664,000.00 | 2,112,912,000.00 | 2,145,887,000.00 | 2,186,690,000.00 | 2,243,469,000.00 |
| Total equity | 2.03B | 2.09B | 2.08B | 2.09B | 2.08B | 2.91B |
| Retained earnings | 937.83M | 926.27M | 904.82M | 892.23M | 885.77M | 900.27M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 258.51M | 296.44M | 314.94M | 457.10M | 484.29M | 365.70M | 173.70M | 184.31M |
| Depreciation & amortization | 161.86M | 164.46M | 166.23M | 167.04M | 163.99M | 184.37M | 210.65M | 224.74M |
| Free cash flow | 28.61M | 139.80M | 191.34M | 238.73M | 158.98M | 36.29M | -146.38M | -88.99M |
| Dividends paid | -46.51M | -53.44M | -54.97M | -55.75M | -57.19M | -55.63M | -54.67M | -54.24M |
| Stock buybacks / issuance | -- | -- | -- | 0 | -82.97M | -78.68M | -50.41M | -12.53M |
| Ending cash balance | 686.03M | 694.13M | 619.87M | 774.11M | 610.83M | 972.72M | 590.29M | 514.97M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 16.10M | -8.79M | 27.64M | 149.36M | 63.67M | 105.36M |
| Depreciation & amortization | 53.77M | 55.97M | 57.29M | 57.70M | 58.21M | 56.12M |
| Free cash flow | -45.47M | -73.39M | -24.69M | 54.56M | -46.99M | 10.16M |
| Dividends paid | -13.56M | -13.56M | -13.56M | -13.56M | -13.61M | -13.61M |
| Stock buybacks / issuance | -12.54M | 0 | 0 | 10.00K | 0 | 830.25M |
| Ending cash balance | 609.40M | 473.86M | 443.86M | 514.97M | 479.36M | 1.30B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 22.56 | 11.43 | 8.03 | 17.95 | 22.63 | 15.27 | -1.47 | -0.44 |
| ROA %i | 10.53 | 5.27 | 3.92 | 8.90 | 11.58 | 7.99 | -0.75 | -0.22 |
| ROIC %i | 18.64 | 9.20 | 6.95 | 14.05 | 17.42 | 10.97 | -0.95 | 0.35 |
| 5-year avg ROE %i | 4.87 | 5.89 | 8.75 | 11.75 | 16.52 | 15.06 | 12.48 | 10.79 |
| EBIT margin %i | 14.94 | 9.74 | 7.59 | 13.95 | 17.46 | 14.48 | 0.85 | 2.09 |
| FCF / sales %i | 0.94 | 5.24 | 7.65 | 7.37 | 4.55 | 1.07 | -- | -- |
| Current ratioi | 2.77 | 3.27 | 3.02 | 2.90 | 2.92 | 3.32 | 2.70 | 2.62 |
| Quick ratioi | 1.80 | 2.17 | 1.99 | 1.90 | 1.83 | 2.07 | 1.42 | 1.25 |
| Debt / assetsi | 15.92 | 19.16 | 15.95 | 16.34 | 16.42 | 22.35 | 24.94 | 25.35 |
| LT debt / equityi | 35.72 | 38.89 | 30.52 | 31.87 | 29.78 | 41.94 | 49.25 | 50.12 |
| Interest coveragei | 12.36 | 7.72 | 6.02 | 25.78 | 35.65 | 19.60 | 0.91 | 1.66 |
| Revenue CAGR (3Y) %i | 9.67 | 4.81 | -1.27 | 2.21 | 9.44 | 10.79 | -3.22 | -4.26 |
| Net income CAGR (3Y) %i | -- | 49.78 | -- | -4.84 | 37.78 | 38.11 | -- | -- |
| FCF CAGR (3Y) %i | -33.85 | -4.77 | -1.19 | 102.84 | 4.38 | -42.54 | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | -3.14 | -4.11 | -3.59 | -0.44 | 0.11 | 1.13 |
| ROA %i | -1.56 | -2.09 | -1.81 | -0.22 | 0.05 | 0.61 |
| ROIC %i | -1.87 | -2.40 | -1.90 | 0.35 | 0.59 | 1.25 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -0.73 | -1.41 | -0.08 | 2.09 | 2.58 | 3.38 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 2.80 | 2.70 | 2.67 | 2.62 | 2.64 | 1.80 |
| Quick ratioi | 1.48 | 1.33 | 1.28 | 1.25 | 1.19 | 1.12 |
| Debt / assetsi | 26.37 | 24.65 | 24.83 | 25.35 | 25.85 | 21.28 |
| LT debt / equityi | 53.21 | 48.38 | 48.76 | 50.12 | 51.81 | 11.37 |
| Interest coveragei | -0.71 | -1.22 | -0.06 | 1.66 | 2.07 | 2.84 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Resistors is the largest reported line at 24.20% of revenue, across 7 reported segments.
- No single line clears half of revenue; Metal oxide semiconductor field-effect transistors (MOSFETs) is next at 21.26%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Resistors24.20%
Metal oxide semiconductor field-effect transistors (MOSFETs)21.26%
Diodes21.04%
Capacitors17.26%
Inductors11.73%
Optoelectronic Components7.89%
Quote time 2026-10-08 07:40:04 · For reference only, not investment advice and not tailored to your situation.